Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amphiphilic Copolymers for Versatile, Facile, and In Situ Tunable Surface Biofunctionalization.
Ruland A, Schenker S, Schirmer L, Friedrichs J, Meinhardt A, Schwartz VB, Kaiser N, Konradi R, MacDonald W, Helmecke T, Sikosana MKLN, Valtin J, Hahn D, Renner LD, Werner C, Freudenberg U. Ruland A, et al. Among authors: schenker s. Adv Mater. 2021 Oct;33(42):e2102489. doi: 10.1002/adma.202102489. Epub 2021 Aug 25. Adv Mater. 2021. PMID: 34431569
Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do?
Malakouti M, Kataria A, Ali SK, Schenker S. Malakouti M, et al. Among authors: schenker s. J Clin Transl Hepatol. 2017 Dec 28;5(4):394-403. doi: 10.14218/JCTH.2017.00027. Epub 2017 Sep 21. J Clin Transl Hepatol. 2017. PMID: 29226106 Free PMC article. Review.
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators. Zinman B, et al. N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. N Engl J Med. 2015. PMID: 26378978 Free article. Clinical Trial.
In memoriam: Burton Combes, M.D.
Schenker S. Schenker S. Hepatology. 2014 Apr;59(4):1655-6. doi: 10.1002/hep.27051. Hepatology. 2014. PMID: 24500989 No abstract available.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP, Wolinsky JS, Bagulho T, Delhay JL, Dukovic D, Truffinet P, Kappos L; TOWER Trial Group. Confavreux C, et al. Lancet Neurol. 2014 Mar;13(3):247-56. doi: 10.1016/S1474-4422(13)70308-9. Epub 2014 Jan 23. Lancet Neurol. 2014. PMID: 24461574 Clinical Trial.
322 results